Speaker illustration

undefined undefined undefined

Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension

Event: ESC Congress 2023

Topic: Pulmonary Hypertension

Session: Current treatment of pulmonary hypertension: it is all about vasodilators

Thumbnail

ESC 365 is supported by